Krystal Biotech, Inc.
KRYS
$143.96
-$2.34-1.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 681.99M | 616.85M | 597.52M | 588.32M | 559.61M |
| Total Receivables | 111.44M | 103.26M | 104.75M | 97.30M | 103.24M |
| Inventory | 31.04M | 29.94M | 26.51M | 18.58M | 12.18M |
| Prepaid Expenses | 16.88M | 16.75M | 13.27M | 8.96M | 7.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 841.35M | 766.80M | 742.05M | 713.16M | 682.77M |
|
|
|||||
| Total Current Assets | 841.35M | 766.80M | 742.05M | 713.16M | 682.77M |
| Net Property, Plant & Equipment | 158.04M | 158.93M | 161.45M | 163.06M | 165.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 197.00K | 218.00K | 231.00K | 203.00K | 126.00K |
| Total Assets | 1.14B | 1.07B | 1.06B | 982.32M | 917.66M |
|
|
|||||
| Total Accounts Payable | 7.12M | 2.67M | 4.99M | 5.58M | 5.43M |
| Total Accrued Expenses | 66.65M | 59.29M | 52.78M | 43.36M | 31.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.62M | 1.36M | 1.22M | 1.29M | 1.36M |
| Total Finance Division Other Current Liabilities | 11.51M | 16.16M | 43.02M | 39.30M | 33.36M |
| Total Other Current Liabilities | 11.51M | 16.16M | 43.02M | 39.30M | 33.36M |
| Total Current Liabilities | 86.90M | 79.49M | 102.00M | 89.53M | 71.85M |
|
|
|||||
| Total Current Liabilities | 86.90M | 79.49M | 102.00M | 89.53M | 71.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.06M | 8.30M | 6.04M | 6.18M | 6.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.79M | 1.95M | 1.42M | 761.00K | 588.00K |
| Total Liabilities | 97.75M | 89.74M | 109.46M | 96.47M | 78.77M |
|
|
|||||
| Common Stock & APIC | 1.15B | 1.13B | 1.13B | 1.11B | 1.09B |
| Retained Earnings | -106.60M | -144.94M | -180.67M | -226.15M | -253.33M |
| Treasury Stock & Other | 1.16M | 390.00K | -190.00K | 1.51M | -634.00K |
| Total Common Equity | 1.04B | 984.67M | 946.38M | 885.85M | 838.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04B | 984.67M | 946.38M | 885.85M | 838.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04B | 984.67M | 946.38M | 885.85M | 838.89M |
|
|
|||||